8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Healthpeak reports flat adjusted FFO and raises 2026 guidance
Filed with the SEC on · Summarized by InvestorsBot
Healthpeak reported second-quarter 2026 net income of $0.08 per share and adjusted FFO of $0.46 per share, unchanged from a year earlier, while occupancy rose to 90.7% in outpatient medical properties and 78.5% in labs. The company raised its 2026 adjusted FFO guidance to $1.73-$1.77 per share and expects $1.75 billion in year-to-date proceeds from transactions, including $1.025 billion from selling a 49% stake in an outpatient medical joint venture with Brookfield; it also authorized a new $500 million share repurchase program.